Advertisement
Research Article| Volume 17, ISSUE 4, P791-798, July 1995

Download started.

Ok

The pharmaceutical industry in Cuba

  • Robert S. Tancer
    Correspondence
    Address correspondence to: Robert S. Tancer, LLB, LLM, The American Graduate School of International Management, 15249 North 59th Avenue, Glendale, AZ 85306.
    Affiliations
    The American Graduate School of International Management, Glendale, and University of Arizona Medical School, Tucson, Arizona U.S.A.
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Cuba has developed a relatively sophisticated pharmaceutical sector, originally to provide medicinal products for her own population and, more recently, to earn hard currency through exports. Cuba has achieved both of these goals despite the US trade embargo, which isolates Cuba from commercial relations with US firms. Cuba is opening its economy to firms from other countries through the use of joint ventures and other forms of cooperation. US firms are unable to avail themselves of these opportunities, and the opportunities are thus being lost. In the case of pharmaceuticals, the Cubans recognize that they need assistance, particularly in the areas of marketing and packaging. Allowing the participation of US firms in the Cuban pharmaceutical industry could enhance the possibility of improving worldwide health care.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Therapeutics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. 22 USC 6001–6009, P. L./102–484 Sec. 1701–1710.

      2. 22 USC 6002(6), P. L./102–484 Sec. 1703(6).

        • Greenhouse S
        Allies of US seek to block bill tightening Cuban curbs.
        The New York Times. 131995; : A4
      3. H.R. 5323, 102d Congress, 2d Session, Sec. 6, (b)(1)(2).

      4. 22 USC 6003 (b).

      5. a
        • UNICEF, PAHO/WHO, UNFPA
        Cuba's Family Doctor Programme. Ministry of Public Health, Republic of Cuba1992: 1
      6. b
        • UNICEF, PAHO/WHO, UNFPA
        Cuba's Family Doctor Programme. Ministry of Public Health, Republic of Cuba1992: 5
      7. c
        • UNICEF, PAHO/WHO, UNFPA
        Cuba's Family Doctor Programme. Ministry of Public Health, Republic of Cuba1992: 14
      8. d
        • UNICEF, PAHO/WHO, UNFPA
        Cuba's Family Doctor Programme. Ministry of Public Health, Republic of Cuba1992: 15
      9. e
        • UNICEF, PAHO/WHO, UNFPA
        Cuba's Family Doctor Programme. Ministry of Public Health, Republic of Cuba1992: 19
      10. Butler WP. Cuba's Revolutionary Medicine. Ramparts. New England Free Press. n.d. 1,4.

        • Hemmes M
        Hosp Health Net. 1994; (Cuba) (May 5): 53
      11. Cuba: Development of the pharmaceutical industry (Cuba: le developpement de l'industrie pharmaceutique). Bull Int Inform Droit et Pharmacie. No. 9. 12. Abstract from CBNB TCD09490361289312.

      12. Characterization of Biotechnology and the Medical-Pharmaceutical Industry in Cuba. 1994; (First page of text (no pagination))
      13. Cuba offers pharmaceutical joint venture opportunities. Pharm Busin News. 90/04/13. 7. Available Financial Times Business Report (FTBR) Datastar 921120-CV8M5K 9211120.

      14. Cuba to transfer vaccines technology to Brazil (Cuba comeca a transferir know how para Fiocruz fazer vacina no Pais). Gazeta-Mercantil. No. 19632. 10. Abstract from CBNB Item TCD0745031196 9111.

      15. Brazil/Cuba vaccines agreement fails (Cuba descumpre acordo e deixa Brasil vulneravel a meningite). J-Brasil. v. XCIX, no. 208. Abstract from CBNB TCD0622916377 9096.

      16. Cuba: meningitis vaccines exported to Argentina free of import duties. BBC Monitoring Service. February 2, 1994. Source TXLN 402220187-YKME63 940222.

        • Blanco A
        La industria biofarmacéutica en Cuba: posibilidades y desafios/The Cuban biopharmaceutical industry opportunities and challenges.
        Cuba Foreign Trade. 1994; (Enemar): 48-49
      17. Behind Cuban smiles.
        Financial Times. 341994; (Weekend): VIII
      18. Cuban drug industry a rising star.
        Pharm Manufacturing Rev. 1994; : 40
      19. Ukraine: Cuba-Ukrainian agricultural produce to be bartered for medicines. BBC Monitoring Service Soviet Union. BBCSU 7/1/94, 62 TXLN 410170309—4FSBWS 940107.

      20. Cuba: Agreements signed with Iran for exchange of Cuban sugar for Iranian oil. BBC Monitoring Service Latin America. BBCLA 27/4/93, 78 TXLN 304270041—VI31WB930427.

      21. Cuba: Prospects for development of pharmaceutical industry. BBC Monitoring Service Latin America. BBCLA 7/12/93, 66 TXLN 312070191—6U2AAF 931207.

        • Feinsilver J
        Can biotechnology save the revolution?.
        NACLA Report on the Americas. 1993; 26: 9
      22. 22 USC 6004 (c)(4).

      23. Decreto ley 50 sobre asociacion economica entre entidades Cubans y Extranjeras.
        Introduction to copy of law distributed by Cuban Chamber of Commerce and obtained by author in Havana. 1994;
        • Central Intelligence Agency, Directorate of Intelligence
        Cuba: Handbook of Trade Statistics. 1993; (Table 3)